<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Papazoglou A</submitter><funding>National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>NIAID NIH HHS</funding><funding>Burroughs Wellcome Fund</funding><funding>NHLBI NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>2003-2014</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9771864</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>74(12)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is the leading cause of death in patients with SSc with unclear pathogenesis and limited treatment options. Evidence strongly supports an important role for profibrotic secreted phosphoprotein 1 (SPP1)-expressing macrophages in SSc-ILD. This study was undertaken to define the transcriptome and chromatin structural changes of SPP1 SSc-ILD macrophages in order to better understand their role in promoting fibrosis and to identify transcription factors associated with open chromatin driving their altered phenotype.&lt;h4>Methods&lt;/h4>We performed single-cell RNA sequencing (scRNA-Seq) on 11 explanted SSc-ILD and healthy control lung samples, as well as single-cell assay for transposase-accessible chromatin sequenci</pubmed_abstract><journal>Arthritis &amp; rheumatology (Hoboken, N.J.)</journal><pubmed_title>Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease.</pubmed_title><pmcid>PMC9771864</pmcid><funding_grant_id>The University of Pittsburgh holds a Physician‐Sci</funding_grant_id><funding_grant_id>P50 AR060780</funding_grant_id><funding_grant_id>2P50AR060780</funding_grant_id><funding_grant_id>T32 AI089443</funding_grant_id><funding_grant_id>R01 HL123766</funding_grant_id><pubmed_authors>Morse C</pubmed_authors><pubmed_authors>Rojas M</pubmed_authors><pubmed_authors>Papazoglou A</pubmed_authors><pubmed_authors>Tabib T</pubmed_authors><pubmed_authors>Sembrat J</pubmed_authors><pubmed_authors>Huang M</pubmed_authors><pubmed_authors>Lafyatis R</pubmed_authors><pubmed_authors>Lafyatis A</pubmed_authors><pubmed_authors>Bulik M</pubmed_authors><pubmed_authors>Valenzi E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epigenetic Regulation of Profibrotic Macrophages in Systemic Sclerosis-Associated Interstitial Lung Disease.</name><description>&lt;h4>Objective&lt;/h4>Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is the leading cause of death in patients with SSc with unclear pathogenesis and limited treatment options. Evidence strongly supports an important role for profibrotic secreted phosphoprotein 1 (SPP1)-expressing macrophages in SSc-ILD. This study was undertaken to define the transcriptome and chromatin structural changes of SPP1 SSc-ILD macrophages in order to better understand their role in promoting fibrosis and to identify transcription factors associated with open chromatin driving their altered phenotype.&lt;h4>Methods&lt;/h4>We performed single-cell RNA sequencing (scRNA-Seq) on 11 explanted SSc-ILD and healthy control lung samples, as well as single-cell assay for transposase-accessible chromatin sequenci</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-22T13:16:21.21Z</modification><creation>2025-04-06T00:33:35.467Z</creation></dates><accession>S-EPMC9771864</accession><cross_references><pubmed>35849803</pubmed><doi>10.1002/art.42286</doi></cross_references></HashMap>